The backdoor pathway to dihydrotestosterone

Griffin, 2003, Disorders of the testes and the male reproductive tract, 709 Shaw, 2000, Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol, Proc. Natl. Acad. Sci. U. S. A., 97, 12256, 10.1073/pnas.220412297 Wilson, 2002, The marsupial model for male phenotypic development, Trends Endocrinol. Metab., 13, 78, 10.1016/S1043-2760(01)00525-2 Sheffield, 1988, Testicular steroid metabolism during development in the normal and hypogonadal mouse, J. Endocrinol., 119, 257, 10.1677/joe.0.1190257 Ge, 1999, Opposing changes in 3α-hydroxysteroid dehydrogenase oxidative and reductive activities in rat leydig cells during pubertal development, Biol. Reprod., 60, 855, 10.1095/biolreprod60.4.855 Eckstein, 1987, Metabolic pathways for androstanediol formation in immature rat testis microsomes, Biochim. Biophys. Acta, 924, 1, 10.1016/0304-4165(87)90063-8 Frederiksen, 1971, Partial characterization of the nuclear reduced nicotinamide adenine dinucleotide phosphate: Δ 4-3-ketosteroid 5α-oxidoreductase of rat prostate, J. Biol. Chem., 246, 2584, 10.1016/S0021-9258(18)62328-2 Auchus, 1998, Cytochrome b5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer, J. Biol. Chem., 273, 3158, 10.1074/jbc.273.6.3158 Wilson, 2003, 5α-androstane-3α,17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α,17α-diol-20-one as a key intermediate, Endocrinology, 144, 575, 10.1210/en.2002-220721 Matsumoto, 1976, Progesterone metabolism in vitro by rabbit testes at different stages of development, Endocrinology, 99, 1269, 10.1210/endo-99-5-1269 Mahendroo, 2004, Steroid 5α-reductase 1 promotes 5α-androstane-3α,17β-diol synthesis in immature mouse testes by two pathways, Mol. Cell. Endocrinol., 222, 113, 10.1016/j.mce.2004.04.009 Mahendroo, 2001, Unexpected virilization in male mice lacking steroid 5α-reductase enzymes, Endocrinology, 142, 4652, 10.1210/en.142.11.4652 Gupta, 2003, 5α-reduced C21 steroids are substrates for human cytochrome P450c17, Arch. Biochem. Biophys., 418, 151, 10.1016/j.abb.2003.07.003 Siiteri, 1974, Testosterone formation and metabolism during male sexual differentiation in the human embryo, J. Clin. Endocrinol. Metab., 38, 113, 10.1210/jcem-38-1-113 Backstrom, 1986, The human corpus luteum secretes 5α-pregnane-3,20-dione, Acta Endocrinol. (Copenh.), 111, 116, 10.1530/acta.0.1110116 Milewich, 1995, Women with steroid 5α-reductase 2 deficiency have normal concentrations of plasma 5α-dihydroprogesterone during the luteal phase, J. Clin. Endocrinol. Metab., 80, 3136, 10.1210/jc.80.11.3136 Ehrmann, 1992, Detection of functional ovarian hyperandrogenism in women with androgen excess, N. Engl. J. Med., 327, 157, 10.1056/NEJM199207163270304 Rosenfield, 1994, Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism, J. Clin. Endocrinol. Metab., 79, 1686, 10.1210/jc.79.6.1686 Nestler, 1996, Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome, N. Engl. J. Med., 335, 617, 10.1056/NEJM199608293350902 Flück, 2003, The 17, 20-lyase activity of cytochrome P450c17 from human fetal testis favors the Δ5 steroidogenic pathway, J. Clin. Endocrinol. Metab., 88, 3762, 10.1210/jc.2003-030143 Thompson, 1990, Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women, Clin. Endocrinol. (Oxf.), 32, 283, 10.1111/j.1365-2265.1990.tb00868.x Falsetti, 1998, Serum levels of 3α-androstanediol glucuronide in hirsute and non hirsute women, Eur. J. Endocrinol., 138, 421, 10.1530/eje.0.1380421 Fassnacht, 2003, Beyond adrenal and ovarian androgen generation: Increased peripheral 5α-reductase activity in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 88, 2760, 10.1210/jc.2002-021875 White, 2000, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Endocr. Rev., 21, 245, 10.1210/er.21.3.245 Flück, 2004, Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome, Nat. Genet., 36, 228, 10.1038/ng1300 Arlt, 2004, Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study, Lancet, 363, 2128, 10.1016/S0140-6736(04)16503-3 Miller, 2004, P450-oxidoreductase deficiency: A new disorder of steroidogenesis with multiple clinical manifestations, Trends Endocrinol. Metab., 15, 311, 10.1016/j.tem.2004.07.005 Bongiovanni, 1962, The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase, J. Clin. Invest., 41, 2086, 10.1172/JCI104666 Rhéaume, 1992, Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene, Nat. Genet., 1, 239, 10.1038/ng0792-239 Moisan, 1999, New insight into the molecular basis of 3β-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes, J. Clin. Endocrinol. Metab., 84, 4410, 10.1210/jc.84.12.4410 Shackleton, 2003, Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome, Steroids, 68, 707, 10.1016/S0039-128X(03)00115-6 Yanagibashi, 1986, Role of electron transport in the regulation of the lyase activity of C-21 side-chain cleavage P450 from porcine adrenal and testicular microsomes, J. Biol. Chem., 261, 8429, 10.1016/S0021-9258(19)83930-3 Geller, 1997, The genetic and functional basis of isolated 17,20 lyase deficiency, Nat. Genet., 17, 201, 10.1038/ng1097-201 Auchus, 1999, Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase): Insights into reaction mechanisms and effects of mutations, Mol. Endocrinol., 13, 1169, 10.1210/me.13.7.1169 Cragun, 2004, Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome, Am. J. Med. Genet., 129A, 1, 10.1002/ajmg.a.30170 Shackleton, 2004, Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): A disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype, Am. J. Med. Genet., 129A, 105, 10.1002/ajmg.a.30171 Penning, 2000, Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones, Biochem. J., 351, 67, 10.1042/0264-6021:3510067 Nishizawa, 2000, Close kinship of human 20α-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes, Genes Cells, 5, 111, 10.1046/j.1365-2443.2000.00310.x Suzuki, 2000, Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies, Clin. Endocrinol. (Oxf.), 53, 739, 10.1046/j.1365-2265.2000.01144.x